tiprankstipranks
Galectin Therapeutics Inc (DE:PHPN)
FRANKFURT:PHPN
Germany Market
PHPN
Galectin Therapeutics
RESEARCH TOOLSreports

Galectin Therapeutics (PHPN) Stock News & Sentiment

0 Followers
Buy Rating Reaffirmed on GALT as Belapectin Program De-Risked; $11 Price Target Maintained
Premium
Ratings
Buy Rating Reaffirmed on GALT as Belapectin Program De-Risked; $11 Price Target Maintained
17d ago
GALT
Galectin Therapeutics strengthens balance sheet via debt-to-equity conversion
Premium
Company Announcements
Galectin Therapeutics strengthens balance sheet via debt-to-equity conversion
28d ago
8K
GALT
Galectin Advances Belapectin to Phase 3 After FDA Alignment
Premium
Company Announcements
Galectin Advances Belapectin to Phase 3 After FDA Alignment
2M ago
8K
GALT
Galectin Therapeutics (GALT) (GALT) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Galectin Therapeutics (GALT) (GALT) Q4 Earnings Cheat Sheet
5M ago
GALT
Galectin Therapeutics Adds Neurosurgeon Henry Brem to Board
Premium
Company Announcements
Galectin Therapeutics Adds Neurosurgeon Henry Brem to Board
6M ago
8K
GALT
Compelling Risk‑Reward in Galectin Therapeutics: Belapectin’s Differentiated Profile and Biomarker Data Support Buy Rating
Premium
Ratings
Compelling Risk‑Reward in Galectin Therapeutics: Belapectin’s Differentiated Profile and Biomarker Data Support Buy Rating
6M ago
GALT
Galectin Therapeutics Adjusts Key NASH Cirrhosis Trial, Resetting Expectations for GALT
Premium
Company Announcements
Galectin Therapeutics Adjusts Key NASH Cirrhosis Trial, Resetting Expectations for GALT
6M ago
GALT
More DE:PHPN News >

PHPN News on the Web

Buy Rating Reaffirmed on GALT as Belapectin Program De-Risked; $11 Price Target Maintained
TipRanks News
Bullish
Is Galectin Therapeutics Inc (GALT) Overvalued After Q2 Earnings Miss? GF Score: 22/100
GuruFocus News
Bearish
Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus
rttnews
Bullish
Top Biotech Gainers: PLSM Inks Virtual Maternity Care Deal, ICCM Turns Heads, SLN Hits New High
rttnews
Bullish
FDA Alignment Signals Regulatory Clarity for Galectin Therapeutics' Belapectin Phase 3 Program
Market Chameleon
Neutral
Top Biotech Gainers: BOLD Begins Anew, MNPR NDA Filing On Track, GALT Soars On FDA Alignment
rttnews
Bullish
Analysts Offer Insights on Healthcare Companies: Galectin Therapeutics (GALT) and Gilead Sciences (GILD)
TipRanks News
Bullish
Galectin Aligns With FDA Feedback To Advance Belapectin In MASH Cirrhosis And Portal Hypertension
rttnews
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:PHPN’s Media Buzz Sentiment?
Currently, no data Available
What is DE:PHPN’s weekly average amount of articles?
In an average week, 0.75 articles about DE:PHPN are published.
    What is DE:PHPN’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    BMRNBioMarin Pharmaceutical
    SMMTSummit Therapeutics
    ACADACADIA Pharmaceuticals
    ABBVAbbVie
    HQYHealthequity
    Showing the stocks with the most bullish news sentiment over the past week